Wu, Y. L. C., Wang, Z., Dong, X., Li, J., Wu, L., Han, L., Li, X., Zang, A., Li, W., Wen, G., Lin, W., Hu, X., Yang, F., Yu, H., Wang, Q., Li, J. (2025). A phase 2 study of HLX07 plus serplulimab with or without chemotherapy versus serplulimab plus chemotherapy as first-line therapy in advanced squamous non-small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8561